These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 32885740

  • 1. Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study.
    Khan RJ, Jha RK, Singh E, Jain M, Amera GM, Singh RP, Muthukumaran J, Singh AK.
    J Biomol Struct Dyn; 2022 Jan; 40(1):438-448. PubMed ID: 32885740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
    Khan RJ, Jha RK, Amera GM, Jain M, Singh E, Pathak A, Singh RP, Muthukumaran J, Singh AK.
    J Biomol Struct Dyn; 2021 May; 39(8):2679-2692. PubMed ID: 32266873
    [Abstract] [Full Text] [Related]

  • 5. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU, Bhowmick S, Osman SM, Alasmary FA, Almutairi TM, Abdullah DS, Patil PC, Islam MA.
    Arch Biochem Biophys; 2021 Mar 30; 700():108771. PubMed ID: 33485847
    [Abstract] [Full Text] [Related]

  • 6. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC, Ding CH, Li HY, Li ZZ, Chen Y, Li LP, Li WZ, Liu WS.
    J Food Biochem; 2022 May 30; 46(5):e14085. PubMed ID: 35128681
    [Abstract] [Full Text] [Related]

  • 7. Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CLpro from SARS-CoV-2: An integrated in silico approach.
    Jha RK, Khan RJ, Parthiban A, Singh E, Jain M, Amera GM, Singh RP, Ramachandran P, Ramachandran R, Sachithanandam V, Muthukumaran J, Singh AK.
    J Biomol Struct Dyn; 2022 May 30; 40(24):13392-13411. PubMed ID: 34644249
    [Abstract] [Full Text] [Related]

  • 8. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
    Batool A, Bibi N, Amin F, Kamal MA.
    Eur J Pharmacol; 2021 Feb 05; 892():173779. PubMed ID: 33275961
    [Abstract] [Full Text] [Related]

  • 9. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
    Sixto-López Y, Martínez-Archundia M.
    J Comput Chem; 2021 May 15; 42(13):897-907. PubMed ID: 33713492
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
    Shalayel MH, Al-Mazaideh GM, Aladaileh SH, Al-Swailmi FK, Al-Thiabat MG.
    Pak J Pharm Sci; 2020 Sep 15; 33(5):2179-2186. PubMed ID: 33824127
    [Abstract] [Full Text] [Related]

  • 16. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening.
    de Oliveira OV, Rocha GB, Paluch AS, Costa LT.
    J Biomol Struct Dyn; 2021 Jul 15; 39(11):3924-3933. PubMed ID: 32448085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Repurposing immune boosting and anti-viral efficacy of Parkia bioactive entities as multi-target directed therapeutic approach for SARS-CoV-2: exploration of lead drugs by drug likeness, molecular docking and molecular dynamics simulation methods.
    Dinata R, Nisa N, Arati C, Rasmita B, Uditraj C, Siddhartha R, Bhanushree B, Saeed-Ahmed L, Manikandan B, Bidanchi RM, Abinash G, Pori B, Khushboo M, Roy VK, Gurusubramanian G.
    J Biomol Struct Dyn; 2024 Jul 15; 42(1):43-81. PubMed ID: 37021347
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the dual effects of antiviral drugs on SARS-CoV-2 receptors and the ACE2 receptor using structure-based virtual screening and molecular dynamics simulation.
    Jahantigh HR, Ahmadi N, Shahbazi B, Lovreglio P, Habibi M, Stufano A, Gouklani H, Ahmadi K.
    J Biomol Struct Dyn; 2023 Jul 15; 41(13):6051-6073. PubMed ID: 35876061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.